Enzymatic approaches to nicotinic acid synthesis: recent advances and future prospects
- PMID: 40534613
- PMCID: PMC12174410
- DOI: 10.3389/fbioe.2025.1585736
Enzymatic approaches to nicotinic acid synthesis: recent advances and future prospects
Abstract
Biocatalyst-mediated reactions have led to revolutionary transformations in the organic synthesis of pharmaceuticals, drugs, and other chemicals. Nicotinic acid (vitamin B3) is an essential precursor for nicotinamide adenine dinucleotide (NAD+) biosynthesis and is vital for numerous metabolic processes. Since the human body cannot synthesize nicotinic acid, it relies on external sources. Therefore, nicotinic acid synthesis has gained huge attraction. In recent years, the industrial production of nicotinic acid has increasingly shifted from traditional chemical methods to more biocatalytic processes, leveraging the power of biocatalysts. This review highlights the biocatalyst-mediated synthesis of nicotinic-acid- and nitrile-metabolizing enzymes through state-of-the-art omics-based techniques to improve enzyme catalytic efficiency and stability via various approaches. Future research prospects and challenges associated with nicotinic acid production are also discussed.
Keywords: biocatalysis; biotransformation; immobilization; nitrilase; omics technology.
Copyright © 2025 Singh, Kalia, Sambyal, Singh, Kumar and Lee.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures





Similar articles
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst.Enzyme Microb Technol. 2025 Oct;190:110682. doi: 10.1016/j.enzmictec.2025.110682. Epub 2025 May 27. Enzyme Microb Technol. 2025. PMID: 40466383
-
Aerolysin Nanopore Electrochemistry.Acc Chem Res. 2025 Feb 18;58(4):517-528. doi: 10.1021/acs.accounts.4c00630. Epub 2025 Jan 28. Acc Chem Res. 2025. PMID: 39874057 Review.
-
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
-
Examining Canadian Hospitals' Support for Planetary Health Through the Implementation of Green Teams and Sustainability Offices.J Healthc Leadersh. 2025 Jun 11;17:269-284. doi: 10.2147/JHL.S517669. eCollection 2025. J Healthc Leadersh. 2025. PMID: 40525086 Free PMC article.
References
-
- Almatawah Q. A., Cowan D. A. (1999). Thermostable nitrilase catalysed production of nicotinic acid from 3-cyanopyridine. Enzyme Microb. Technol. 25 (8-9), 718–724. 10.1016/S0141-0229(99)00104-0 - DOI
-
- Badoei-Dalfard A., Karami Z., Ramezani-pour N. (2016). Bench scale production of nicotinic acid using a newly isolated Stenotrophomonas maltophilia AC21 producing highly-inducible and versatile nitrilase. J. Mol. Catal. B Enzym 133, S552–S559. 10.1016/j.molcatb.2016.11.019 - DOI
Publication types
LinkOut - more resources
Full Text Sources